Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Print1
- Exam Prep1
- Article Type
- Research Support, Non-U.S. Gov't1
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Rev Infect Dis1
Search Results
Sort by
year (new to old)
- BookPuneet K. Gupta, MD, MSE, Assistant Professor, Department of Neurology and Neurotherapeutics, ... Show More University of Texas Southwestern Medical Center, Dallas, Texas, Pradeep Modur, MD, MS, Associate Professor, Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, Srikanth Muppidi, Clinical Assistant Professor, Department of Neurology and Neurological Sciences, Stanford School of Medicine, Stanford, California.Contents:
Anatomy and physiology
Electronics and instrumentation
Nerve conduction studies and electromyography (EMG)
Electroencephalography (EEG)
Evoked potentials and intraoperative monitoring (IOM)
Polysomnography and other sleep studies (PSG)
Advanced topics : high frequency oscillations (HFOs), DC shifts, transcranial electrical stimulation (TES), motor evoked potential (MEP), transcranial magnetic stimulation (TMS), magnetoencephalopgraphy (MEG), autonomic testing, blink reflex, single fiber EMG (SFEMG), quantitative EEG (QEEG)
Ethics and safety. - ArticleWeinstein MP, Eickhoff TC.Rev Infect Dis. 1979 Jan-Feb;1(1):158-64.A clinical trial was designed for evaluation of the efficacy, safety, and patient tolerance of cefoxitin. Of 26 patients who could be evaluated clinically, 21 had respiratory tract infections; all but one patient responded satisfactorily to therapy with cefoxitin. There were no adverse systemic reactions, nor was any renal or hematologic toxicity noted. In two instances levels of hepatic enzymes became slightly elevated; these changes were possibly related to administration of cefoxitin. About one-third of patients receiving cefoxitin developed minor local reactions at the site of intravenous administration; however, there was only a single instance of true thrombophlebitis. Results of this study suggest that cefoxitin is a safe and well-tolerated antibiotic that is efficacious in therapy of acute respiratory tract infections caused by bacteria that are sensitive to this drug.